Glaxo Sales Fall in China as Inquiry Continues
Thursday, October 24, 2013 - 16:20
in Mathematics & Economics
The drug giant reported that third-quarter product sales in China, where it faces a continuing bribery investigation, dropped 61 percent as rivals grabbed market share.